How Common is Iron Deficiency Anemia?
Although the prevalence of iron deficiency anemia has decreased since the 1970s, it is still a concern for infants, children, pregnant women and women of childbearing age, certain ethnic groups, and low-income groups.1,2,3,4,5
General Population
Data from a nationally representative study, the third National Health and Nutrition Examination Survey (1988-1994), showed that 11% of non-pregnant women between age 16 and 49 were iron deficient, and up to 5% also had iron deficiency anemia. This means approximately 3 million women in the United States may have iron deficiency anemia.3
Subpopulations
The prevalence of iron deficiency anemia varies depending on the subset of the population discussed. For example, studies in the US and abroad have found prevalence of IDA is higher among athletes and female military recruits than among the general population.6,7,8
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Ferralet® 90 is a prescription iron supplement approved for treating anemias that respond to oral iron therapy. Your doctor may prescribe Ferralet® 90 if you have certain anemias associated with pregnancy, blood loss, or metabolic disease, or if you are recovering from surgery or do not have enough iron in your diet.
Important Safety Information
Ferralet® 90 has not been tested in children. Dosing for elderly patients should begin at the lower end of the dosing range.
Talk to your doctor before taking Ferralet® 90 if you have a known sensitivity to any of its ingredients.
Because some medications may interact with Ferralet® 90, you should tell your doctor about any medications you are taking, including antacids and antibiotics.
Before prescribing iron therapy, your doctor will need to determine the type of anemia you have and identify its underlying causes. You should not take this product if you have been diagnosed with hemolytic anemia or an iron overload disorder such as hemochromatosis or hemosiderosis.
If you have certain forms of anemia associated with vitamin B12 deficiency (i.e. pernicious anemia), the Folic acid contained in Ferralet® 90 is not enough to treat your condition. Doses of more than 0.1 mg Folic acid per day can hide the symptoms of these anemias, so your doctor must rule them out before prescribing this product.
Once you begin iron therapy with Ferralet® 90, take the product 2 hours after meals, and do not exceed the recommended dose.
When taking Ferralet® 90, you may experience temporary side effects such as GI irritation, constipation, diarrhea, nausea, vomiting, and dark stools.
Some patients taking Folic acid have reported allergic reactions. Additionally, Ferralet® 90 contains FD&C Yellow No. 5 (tartrazine), which may cause allergic reactions (including bronchial asthma) in certain susceptible people. Although uncommon, tartrazine sensitivity is often seen in patients who also have aspirin hypersensitivity. Contact your doctor and discontinue use if you develop any unusual symptoms.
Keep this product out of reach of children. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six. Symptoms of overdose include abdominal pain, metabolic acidosis, decline or absence of urine production, nerve damage, coma, convulsions, death, dehydration, congestion of blood vessels, cirrhosis of the liver, low blood pressure, hypothermia, fatigue, nausea, vomiting, diarrhea, black or tarry stools, vomiting blood, rapid heart rate, high blood sugar, drowsiness, abnormal pale or bluish skin color, lack of energy, seizures, and shock. In case of accidental overdose, call a doctor or poison control center immediately.
To report negative side effects, contact Mission Pharmacal Company at 1-800-298-1087 or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
- Rules and Regulations. Fed Regist. 1997;62(10):2239.
- Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA. 1997 Mar 26;277(12):973-6.
- Iron deficiency--United States, 1999-2000 [Internet]. Centers for Disease Control and Prevention (CDC); 2002 Oct 11 [accessed 2008 Apr 9]. Available from: http://www.cdc.gov/MMWR/preview/mmwrhtml/mm5140a1.htm.
- Dietary supplement fact sheet: iron [Internet]. National Institutes of Health Office of Dietary Supplements; 2007 Aug 24 [cited 2008 Apr 20]. Available from: http://ods.od.nih.gov/factsheets/iron.asp.
- Killip S, Bennett JM, Chambers MD. Iron deficiency anemia. Am Fam Physician. 2007 Mar 1;75(5):671-8.
- McClung JP, Marchitelli LJ, Friedl KE, Young AJ. Prevalence of iron deficiency and iron deficiency anemia among three populations of female military personnel in the US Army. J Am Coll Nutr. 2006 Feb;25(1):64-9.
- Dubnov G, Foldes AJ, Mann G, Magazanik A, Siderer M, Constantini N. High prevalence of iron deficiency and anemia in female military recruits. Military Medicine. 2006 Sep;171(9):866-9.
- Dubnov G, Constantini NW. Prevalence of iron depletion and anemia in top-level basketball players. International Journal of Sport Nutrition and Exercise Metabolism. 2004 Feb;14(1):30-7.
